Search For "pharma"
Glenmark to conduct phase III trials of nasal spray it claims to be effect
Updated : 4 years, 8 months ago IST
New Delhi [India], July 8 (ANI): Glenmark Pharmaceuticals will be conducting a Phase III trial on a nasal spray, which it claims to be effective in the treatment of COVID-19.
Read More
Sensex drops 486 points, metals and banks crack
Updated : 4 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 8 (ANI): Equity benchmark indices ended nearly a per cent lower on Thursday, dragged by bank, metal and pharma names amid pessimistic global cues.
Read More
Sanofi, GSK receive approval for Phase 3 trial of COVID vaccine in India
Updated : 4 years, 8 months ago IST
New Delhi [India], July 8 (ANI): French pharmaceutical company Sanofi and its British partner GSK (GlaxoSmithKline plc) received approval for their Phase 3 clinical study in India, to assess the safety, efficacy and immunogenicity of their adjuvanted recombinant-protein COVID-19 vaccine cand
Read More
Pharmaceutical market reports 14 pc growth in June
Updated : 4 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 7 (ANI): India Ratings and Research (Ind-Ra) has said the 14.1 per cent y-o-y growth in pharmaceutical market during June was led by a normalisation of demand post high growth months of April (51.5 per cent) and May (47.8 per cent).
Read More
Making socially affordable drug market, StayHappi Pharmacy takes on growth
Updated : 4 years, 8 months ago IST
New Delhi [India], July 7 (ANI/The PRTree): The growth and structure of pharmaceutical industry have impact on healthcare expenditure. Healthcare expense is of a major global concern and so as the high drug prices.
Read More
Fitch affirms Glenmark Pharmaceuticals at BB with stable outlook
Updated : 4 years, 8 months ago IST
Singapore, July 6 (ANI): Fitch Ratings has affirmed Glenmark Pharmaceuticals Ltd's long-term issuer default rating at BB with a stable outlook.
Read More
India in talks with Johnson & Johnson for single-dose COVID-19 vaccine
Updated : 4 years, 8 months ago IST
New Delhi [India], July 2 (ANI): NITI Aayog member (Health) Dr VK Paul on Friday confirmed that India is in talks with US pharma giant Johnson & Johnson for their single-dose COVID-19 vaccine named Janssen.
Read More
Don't need Phase 3 trials, Sputnik Light vaccine can submit Russian safety
Updated : 4 years, 8 months ago IST
New Delhi [India], July 1 (ANI): Sputnik vaccine's India-partner Dr Reddy's on Thursday informed that the government panel has told the pharma firm that it does not need to conduct Phase 3 trials for Sputnik Light and only require to submit Russian safety data for approval in India.
Read More
Zydus Cadila seeks nod for its COVID-19 vaccine ZyCoV-D, aims to produce 1
Updated : 4 years, 8 months ago IST
New Delhi [India], July 1 (ANI): The pharmaceutical firm Zydus Cadila on Thursday informed that it has applied for emergency use authorisation (EUA) from the Drug Controller General of India (DCGI) for its DNA vaccine ZyCoV-D against coronavirus disease and stated that they expect to produce
Read More
Blended Curriculum of Business Applications and Technology - Advantage MCA
Updated : 4 years, 8 months ago IST
New Delhi [India], July 1 (ANI/Mediawire): The exponential growth in the science of numbers and computing techniques have helped mankind scale newer and greater heights.
Read More
Zydus Cadila seeks emergency use authorisation for ZyCoV-D COVID-19 vaccin
Updated : 4 years, 8 months ago IST
New Delhi [India], July 1 (ANI): Pharmaceutical major Zydus Cadila on Thursday applied for Emergency Use Authorisation (EUA) seeking approval from the Drugs Controller General of India (DCGI) for the launch of their ZyCoV-D vaccine for 12 years and above, sources said .
Read More
South Korea: K-mRNA Consortium to be launched, 'will produce 100 million d
Updated : 4 years, 8 months ago IST
Seoul [South Korea], June 30 (ANI/Global Economic): South Korea's pharmaceutical industry launched the 'Next Generation mRNA Vaccine Platform Technology Consortium' (K-mRNA Consortium) to produce more than 100 million doses of mRNA-based vaccine and get approved.
Read More